In systemic DLBCL, the absence of nuclear expression of TXNDC2 is correlated with one or no extranodal effusion at all (p = 0.044), whereas nuclear negativity in testicular DLBCL is associated with worse primary treatment response (p = 0.044). This evidence concerns the gene TXNDC2 and diffuse large B-cell lymphoma.